Community-based eye care is one of Orbis’s top priorities in the country.
One practice’s experience with office-based surgery validates peer-reviewed study.
Clear communication, transparent priceing, options are key to positive experience
Novel treatments are now shifting paradigm in care of retinal diseases.
Balancing motherhood & ophthalmology: Prioritize family planning, set boundaries, integrate work & personal life. Insights from ophthalmologist-moms.
Aleksandra Rachitskaya, MD, discusses how the treatment landscape for inherited retinal diseases has changed and her hope for the future.
Minimizing clinic visits, maximizing use of imaging modalities are key.
SLT shows promise as treatment for millions of Africans with glaucoma.
An ophthalmologist presents the case of a 76-year-old woman who has geographic atrophy and progressively worsening vision in her right eye, with a history of macular macrovessel and choroidal hemangioma.
Details enhance knowledge of biological pathways that contribute to disease pathogenesis.
Ophthalmologists seek methods to control postoperative inflammation.
Closing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
The collaboration agreement will allow the 2 companies to find a potential new treatment for chronic dry eye disease.
In ophthalmology, women continue to take on leadership roles and make a difference in the profession.
Using an NSAID to Manage Inflammation and Pain After Cataract Surgery
In observance of International Holocaust Remembrance Day this January 27, John H. Merey, MD, may be the only Holocaust survivor still in the practice of ophthalmology.
Experts discuss the use of steroids, particularly in the context of diabetic macular edema (DME). The inflammatory nature of DME reveals the effectiveness of steroids, especially in cases where persistent fluid remains despite anti-VEGF treatment.
Technology offers accessibility, scalability to countries where care is needed the most.
Aggressive lubrication combined with topical steroids, antibiotics boosts chances of recovery.
Two trials examine factors affecting the risk of disease.
During the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Several hundred genes are associated with congenital forms.
Factors that lead to complications must be managed for best outcomes.
Details enhance knowledge of biological pathways that contribute to disease pathogenesis.
Treatment requires a systematic, multifaceted approach to improve outcomes.
John Doane, MD, discusses latest advancements in laser technology that enhance the surgical experience, speed, and precision of the SMILE procedure.
BRIO-1 clinical trial sowing optimism as a potential therapeutic option.